We are delighted to welcome Professor Claudia Langenberg, Director of the Precision Healthcare University Research Institute (PHURI) at Queen Mary University of London, to discuss the future of precision medicine. With an impressive background as Professor of Computational Medicine at the Berlin Institute of Health at Charité Universitätsmedizin, Germany, and former Programme Leader at the MRC Epidemiology Unit at the...
The UK Science Park Association (UKSPA) is a not-for-profit Membership organisation representing Science Parks and innovation locations across the UK. Their Members span Science Park owners, investors and developers, as well as supporting professional service firms. UKSPA Members are linked to strategic innovation sectors for the UK, including Life Sciences. UKSPA’s purpose is to share best practice amongst their Members...
Queen Mary Innovation (QMI) is dedicated to maximising the economic and social impact of Queen Mary’s research using commercial tools. They protect and license intellectual property while building sustainable enterprises and social ventures to bring Queen Mary’s cutting-edge research to a global audience. QMI currently has a portfolio of nearly 30 companies across diverse industries. They create three new spinouts...
Barts Health NHS Trust and Barts Life Sciences have joined forces with Capital City College Group (CCCG) to establish Barts Health Futures, a pioneering Health and Life Sciences Skills Hub. The partnership, marked by a signing ceremony at CCCG’s Angel centre, will offer diverse education and qualification pathways to students across London, equipping them with essential skills for the healthcare...
A pioneering AI technology designed to speed up patient care through improved assessment in the emergency department is currently being trialled at the Royal London Hospital (RLH) as part of a groundbreaking collaboration between Bingli, Barts Health and Barts Life Sciences (BLS). Emergency Departments (ED) are under significant pressure, with the four-hour wait time target consistently missed. BLS is at...
Clinical trials are important for helping to improve health outcomes for our community. A Clinical Research Facility (CRF) is both a physical place and importantly a team of skilled healthcare professionals who help to deliver research studies. Barts Health is a highly research-active organisation, and last year recruited more people into clinical trials than ever before. Next year, we will...
The healthcare research landscape has advanced dramatically in the past decade. Breakthroughs in areas such as genomics now enable us to diagnose and treat diseases with unprecedented precision. In this blog post, we spoke with Professor Sir Mark Caulfield, Vice Principal for Health Queen Mary University of London, Faculty of Medicine and Dentistry and Director of the NIHR Barts Biomedical...
UK Science Parks and Innovation Districts have long been pivotal engines of economic growth, driving technological innovation, economic development, and enhancing global competitiveness. In this blog, Dr. Grant Bourhill, MD at Barts Life Sciences and Board Director of the UK Science Park Association, explores the evolution of these clusters over the past few decades and the anticipated benefits of the...
A project using Artificial Intelligence to tackle cardiovascular healthcare inequalities in North East London has been awarded over £300,000 by Barts Charity. The PREDICT project will use patient data to predict and prevent emergency admissions to hospital for patients with heart valve disease. The 3-year project will translate medical notes into structured data which is suitable for identifying groups...
In a new collaboration with Barts Health’s Clinical Haematology team and Sanofi, Barts Life Sciences (BLS) aims to speed up diagnosis – and in turn treatment – of rare diseases. Rare diseases aren’t as rare as you might think. In fact, 1 in 17 people in Europe will be diagnosed with one. But despite being more common than originally imagined,...
Accessibility options
Translate the page